aid: eikon-therapeutics
name: Eikon Therapeutics
description: 'Eikon Therapeutics is a biopharmaceutical company (Nasdaq: EIKN) founded in 2019 and
  headquartered in Millbrae, California, with additional offices in New York and Jersey City. Eikon
  built a proprietary drug-discovery platform around single-molecule live-cell imaging, applying
  super-resolution fluorescence microscopy and high-throughput single-molecule tracking to observe
  how proteins and drug targets move and interact inside living cells in real time. The technology
  descends from co-founder Eric Betzig''s Nobel Prize-winning work in super-resolution microscopy,
  and the company is led by former Merck R&D chief Roger Perlmutter. Eikon uses these measurements to
  discover and develop novel therapeutics across oncology and other disease areas. This profile was
  surfaced as a portfolio company of Lux Capital and enriched by the API Evangelist pipeline; Eikon
  publishes a corporate and investor web presence but no public developer API, SDK, or machine-readable
  API surface at this time.'
url: https://raw.githubusercontent.com/api-evangelist/eikon-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lux-capital
x-tier: stub
x-tier-reason: portfolio-lead
x-ticker: EIKN
x-hq: Millbrae, California, United States
x-founded: '2019'
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.eikontx.com/wp-content/uploads/2023/12/logo-eikon.png
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotech
- Biopharmaceutical
- Drug Discovery
- Live-Cell Imaging
- Super-Resolution Microscopy
- Oncology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/eikon-therapeutics-domain-security.yml
- type: Website
  url: https://www.eikontx.com
- type: About
  url: https://www.eikontx.com/about-us/
- type: News
  url: https://www.eikontx.com/news/
- type: Careers
  url: https://www.eikontx.com/careers/
- type: Contact
  url: https://www.eikontx.com/contact/
- type: Investors
  url: https://investors.eikontx.com/
- type: PrivacyPolicy
  url: https://www.eikontx.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/eikon-therapeutics-inc/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence